A Bloomberg Professional Service Offering

A Portfolio Manager & Analyst Guide to Bloomberg’s Spotlight on Pharma and Biotech

CONTENTS

03 DEDICATED PHARMA RESEARCH DASHBOARDS: BI <GO> 03 ROBUST DATA AT YOUR FINGERTIPS: BI <GO>04 SUPERIOR NEWS COVERAGE: FIRST <GO>04 IDEA GENERATION: EQS <GO> & EQRV <GO>05 FUNDAMENTALS & EARNINGS: FA <GO> & EE <GO>05 PORTFOLIO ANALYSIS: PORT <GO>06 POWERFUL DOCUMENT SEARCH: DS <GO>

To spotlight our in-depth coverage of the pharma sector, we are excited to introduce Focus on Pharma, a multi-week program of increased media coverage to demonstrate the pharmaceutical and biotech expertise that Bloomberg brings to the sector daily.

Analyzing the pharmaceutical and biotech industries requires access to expensive data sets, including drug pipelines with upcoming catalysts, drug revenue forecasts, prescriptions and litigation, specialized analytics and a variety of news sources that can push costs to the tipping point — nearly $70,000 per person — for many trading firms.

With extensive data sets, robust analytics and a team of news and research experts covering the sector, Bloomberg is able to help analysts and portfolio managers keep ahead of the curve, offering the resources to develop and communicate creative investment ideas, to get smart quickly on an industry trend, and to fuel their data models to enable them to deliver profitable trading recommendations.

Stay tuned for an exciting lineup of coverage across Bloomberg media beginning June 27th.

INTRODUCING FOCUS ON PHARMA

BLOOMBERG MEDIA FOCUS ON PHARMA COVERAGE

Bloomberg Television & Bloomberg Radio

Special guests and additional pharma-related segments

Bloomberg Markets magazine Special Pharma & Biotech section featuring Bloomberg Intelligence analysts

Bloomberg Businessweek Focus On: Pharma special section

Bloomberg.com A new section added to Bloomberg.com that consoidates our pharma news

Bloomberg Briefs Special industry brief featuring in-depth content from Bloomberg Intelligence and Bloomberg News

Bloomberg News Discover more interactive graphics and charts on pharma

FOCUS ON PHARMA // 02

DEDICATED PHARMA RESEARCH DASHBOARDS: BI <GO> Bloomberg Intelligence (BI), the research arm of Bloomberg L.P., offers independent, comprehensive research analysis and data on pharma and biotech — all on the Bloomberg Terminal.

BI takes a unique approach to aggregating information for analysts and portfolio managers by organizing analytics, data and insights in consolidated dashboards.

Below is an example of the BI dashboard for large pharma. Our industry research is geared to arm IR professionals with deep analysis and key takeaways that drive investment decisions and to enable them to delve into issues that impact performance. You can also directly access the BI analysts if you want to discuss a specific issue or piece of research.

In addition, BI offers company primers that provide a 360° view on company-specific KPIs and how competitive and sector trends, regulation or litigation impact your company.

ROBUST DATA AT YOUR FINGERTIPS: BI <GO>Both through BI and across the Terminal, you will find exhaustive clinical trial and drug pipeline data, robust drug-specific event calendars, prescription and institutional data, drug sales and revenue forecasts, and patent and product liability litigation — all proprietary from Bloomberg or third-party sources.

Specifically, this includes:- Global drug pipeline data, including more than 5,000 private company drug portfolios

- 7+ years of Symphony’s monthly retail and institutional data and 5+ years of weekly prescription data

- 5+ years of First Data Bank’s drug-pricing data

- Epidemiological models and NPV calculators for more than 75 indications

- Catalyst calendars from clinical and regulatory milestones to litigation

Bloomberg Intelligence Pharma Dashboard – BI PHRMG <GO>

Symphony Health Solutions data

FOCUS ON PHARMA // 03

SUPERIOR NEWS COVERAGE: FIRST <GO>Bloomberg offers an array of news and social media functionality on the pharmaceutical industry directly through the Bloomberg Terminal.

Our First Word offering delivers immediate updates and a concise first take on key news events that could have ramifications for the pharma industry. Filters and alerts allow you to monitor industry-specific news or news on a custom peer list.

IDEA GENERATION: EQS <GO> & EQRV <GO>Not only does Bloomberg offer the key pharma news, research and data needed to monitor companies and the competition, there is specific functionality available to analysts and portfolio managers to help them generate new trading ideas on their industry and company coverage.

Bloomberg displays propri-etary news coverage, sell-side and proprietary research, as well as news from third-party sources.

You can also stay on top of the social media sentiment on the companies you follow with Twitter filters and social media analytics.

Equity Screening — EQS <GO> allows you to screen for companies that meet a customized set of criteria so you can generate investment ideas, create lists of securities to follow and validate your trade ideas by viewing historical performance.

In addition, you can create criteria based on categories such as sectors or countries, as well as on fundamentals, estimates and financial ratios. You can analyze growth, trends and estimate revisions over time and compare data against benchmarks or relative data.

Equity Relative Valuation — EQRV <GO> is designed to help identify investment opportunities by evaluating which stocks are trading unusually rich or cheap in relation to a common group. It enables you to view relative valuation over time and study the impact of news on certain companies.

First Word — FIRST <GO>

Equity Relative Valuation – EQRV <GO>

FOCUS ON PHARMA // 04

FUNDAMENTALS & EARNINGS: FA <GO> & EE <GO>Bloomberg is the go-to resource to take a deep dive into a specific company for financial analysis purposes. Portfolio managers and analysts have multiple functions to help them get a complete picture of a company’s financial health, including:

Financial Analysis — FA <GO> provides comprehensive financial information for a company, including historical fundamental data and future estimates. FA allows you to identify trends, gain data transparency and compare financial statements so you can analyze the value of a potential investment, partnership or acquisition target

Earnings & Estimates — EE <GO> provides a snapshot of aggregated broker earnings projections, surprise earnings data and a summary of earnings history so you can see a broad range of data for a specific equity. The data is synced with the company’s reporting calendar, which allows you to anticipate and prepare for upcoming announcements and quickly analyze the results from the most recent announcement.

PORTFOLIO ANALYSIS: PORT <GO>Performance depends on a multitude of factors that need to be constantly monitored. You must manage and anticipate changes in complex markets every day, plan for every possibility and execute accordingly.

PORT <GO> empowers you to gain deeper insight into your portfolios by providing the tools to understand the structure of portfolios, analyze positions and active bets and explain the drivers of historical performance and potential sources of future risk.

In addition, PORT provides a streamlined workflow that includes intraday performance monitoring, fundamental characteristics, historical performance attribution, ex-ante tracking error, scenario analysis and portfolio optimization.

Financial Analysis on Biotech and Pharma Segment – FA <GO>

Portfolio & Risk Analytics — PORT <GO>

FOCUS ON PHARMA // 05

POWERFUL DOCUMENT SEARCH: DS <GO>Bloomberg’s Document Search functionality allows you to search through a diverse collection of documents, such as in-depth research reports, public filings, conference transcripts, press releases, slide decks and presentations from more than 1,500 providers, including brokers, independent providers, market research firms and industry associations.

. You can perform searches on securities, lists and keywords to quickly discover the documents that support your analysis, all in one place. You can then use filters and advanced search capabilities to narrow your search and isolate only the most useful results.

A document search for Pfizer patent information

FOCUS ON PHARMA // 06

LEARN MOREThis is only a glimpse of what Bloomberg has to offer the portfolio manager and analyst in the pharma and biotech community. Contact your sales representative for a complete demo.

BEIJING +86 10 6649 7500

DUBAI +971 4 364 1000

FRANKFURT +49 69 9204 1210

HONG KONG +852 2977 6000

LONDON +44 20 7330 7500

MUMBAI +91 22 6120 3600

NEW YORK +1 212 318 2000

SAN FRANCISCO +1 415 912 2960

SÃO PAULO +55 11 2395 9000

SINGAPORE +65 6212 1000

SYDNEY +61 2 9777 8600

TOKYO +81 3 3201 8900

bloomberg.com The data included in these materials are for illustrative purposes only. ©2016 Bloomberg L.P. All rights reserved. S694398580 DIG 0616

ABOUT THE BLOOMBERG PROFESSIONAL® SERVICEBloomberg, the global business and financial information and news leader, gives influential decision makers a critical edge by connecting them to a dynamic network of information, people and ideas. The company’s strength — delivering data, news and analytics through innovative technology, quickly and accurately — is at the core of the Bloomberg Professional service, which provides real-time financial information to more than 325,000 subscribers globally. Headquartered in New York, Bloomberg employs more than 19,000 people in 192 locations around the world.